Abstract
INTRODUCTION

77
Chronic pancreatitis (CP) is a progressive inflammatory disorder characterized by 78 repeated attacks of abdominal pain, fibrosis, and destruction of the glandular 79 pancreas (15, 29, 39). Pain is a cardinal feature of CP, featured as burning, 80 intermittent, and shooting pain (13). It is not only the most frequent and dominant 81 symptom of CP patients but also the most difficult to treat (1, 3, 22, 35) . Our lack 82 of knowledge about what causes pain in pancreatitis has been a serious obstacle 83 to treatment on these patients, with pain frequently relapsing or persisting (1, 31) . 
94
Spinal afferents predominantly display homomeric P2X3 and heteromeric P2X2/3 95 subtypes and this system has been shown to be important in several animal 96 models of visceral injury including the urinary bladder (12, 24) and the colon (42).
97
In inflammatory pancreas, ATP may release from macrophages and acinar cells 98 that then acts on P2X3 homomeric and P2X2/3 heteromeric receptors on 99 intramural spinal nerves triggering pain signaling in pancreas (26). Further, this 100 pathway appears to be amplified in inflammatory conditions. Although these data 101 imply a role for purinergic receptors in pancreatic inflammation, it is unknown 102 whether they also contribute to pain signaling in pancreatic hyperalgesia.
104
Increased sympathetic activity may also play a role in CP patients with chronic 105 pain syndromes (7). It is reported that increased supine plasma norepinephrine 
117
Our study therefore provides mechanistic insight into painful CP and identifies a 118 potential molecular target for the treatment of pancreatic pain hypersensitivity. 
MATERIALS AND METHODS
121
Animals
122
Experiments were performed on adult male Sprague-Dawley rats (200-220 g).
123
Animals were housed under controlled conditions (07:00, 19:00 lighting, 242C) with 124 free access to a standard laboratory diet and fresh water. Real-time quantitative polymerase chain reaction (qPCR) for mRNA 152 qPCR was performed using SYBR Green fluorescence, as previously described (48) .
153
The sequences of the primers for P2X3 receptors, and -actin (as an internal control) 154 used in qPCR are: P2X3-F: GAACCAGACGGAGCAAACAG, P2X3-R:
155
GGCGAAGGAATCGTCATCA, Actin-F: TCAGGTCATCACTATCGGCA, Actin-R:
156
GGCATAGAGGTCTTTACGGAT.
158
Immunofluorescence study 159 Triple labeling techniques were performed to examine the co-localization of P2X3R
160
and  2 -AR in DRG neurons innervating the pancreas, as described previously (48) . 
RESULTS
227
TNBS injection sensitizes P2X3 receptors
228
We first determined whether TNBS injection enhanced response frequency in rats. (Fig. 6A, CON, n=4 ; TNBS, n=7, **p<0.01) and pancreas (Fig. 6B, CON with aged-matched controls (Fig. 6E, n=4 for each group, *p<0.05). However,
350
expression of  1 (Fig. 6D, n=4 for each group) and  3 (Fig. 6F, n=4 for each group)
351
adrenergic receptors was not significantly altered. We next examined whether
352
P2X3Rs were co-expressed with  2 -AR in DRG neurons innervating the pancreas.
353
Triple-labeling techniques were used in this experiment. Pancreatic projection DRG 354 neurons were retrogradely labeled by DiI (Fig. 6G) immunoreactive for P2X3R were also positive for  2 adrenoceptor (Fig. 6L) . Similarly,
359
all pancreatic projection DRG neurons that were immunoreactive for  2 -AR also were 360 positive for P2X3R (Fig. 6L ).
362
Adrenergic  2 -receptor inhibitor attenuates pancreatic hyperalgesia 363 We then determined whether adrenergic signaling is involved in TNBS-induced weight significantly reduced nociceptive responses in CP rats (Fig. 7D) . The effect of
373
Buto at doses of 1.5 mg/kg body weight lasted for ~1 hour (Fig. 7E, n=8 An interesting finding of the present study is that adrenergic signaling is involved The mechanism by which adrenergic signaling sensitizes P2X3Rs remains largely 471 unknown. In this study, we provided evidence to support an idea that enhanced 472 adrenergic signaling sensitizes P2XRs through a PKA-dependent mechanism. of Rota rod test in healthy control rats. 
